
Derek S Chew
@derek_c1
Cardiac Electrophysiologist @UCalgary @LibinInstitute @OBrien_IPH | Alum of DCRI, UCalgary, UofT
ID: 1179524664495882240
02-10-2019 22:32:56
113 Tweet
207 Followers
272 Following

#OriginalResearch In the VICTORIA trial, use of vericiguat in patients with HFrEF was associated with an increased quality-adjusted life expectancy at a cost of $66,509 per QALY Canadian VIGOUR Centre Christopher O'Connor Derek S Chew Daniel Mark ahajournals.org/doi/10.1161/CI…




Derek S Chew eloquently shares data on resource use and cost comparisons in the #PRECISE trial @ #AHA.23 🗝️ points 👇



I'm excited to announce our Alberta Innovates grant which will leverage artificial intelligence to support physician decision-making. We are still looking for Master's student candidates - message me Our work is growing AI expertise in Alberta. Libin Cardiovascular Institute Alberta Innovates



Enjoyed celebrating my nomination for Women of Impact at the Triangle Go Red for Heart Evening in Red! We raised awareness and funding for AHA focusing on Women’s heart health. #aha #GoRed Duke Heart Manesh Patel Jonathan Piccini, MD, MHS Kevin L. Thomas




Combining gated SPECT & vectorcardiography to guide LV lead placement to improve response to CRT. #CRT #SPECT #mechanicaldyssynchrony #electricaldyssynchrony #Vectorcardiography College of Computing ICC @LabMiil. Read now👉bit.ly/4heeEQ6 Editorial by Derek S Chew


🎉 Congrats Dr. Robert Miller, MD, named one of Avenue Calgary's Top 40 Under 40! The professor and cardiologist is using AI to improve cardiac patient care through more accurate and efficient diagnoses. Read about his important work: bit.ly/3YDoEdh Libin Cardiovascular Institute


Consumer Wearables: Advancing Atrial Fibrillation Care or Too Much Information? jamanetwork.com/journals/jamai… via Derek S Chew et al John Mandrola, MD Andrew Foy 𒊓𒅂𒁓𒐗𒐕𒐗 Steve the skeptic

Viewpoint by Derek Chew, Emily Zeitler, & Daniel Mark: While extended ECG monitoring technologies are increasingly detecting subclinical atrial fibrillation (SCAF), the benefits of anticoagulation therapy for this population remain uncertain. ja.ma/3Z7Uwbn



Semaglutide (#Ozempic, Wegovy) can help non-diabetic overweight or obese individuals with #heartdisease and be cost-effective, an article in the Canadian Journal of Cardiology shows spkl.io/6010f5dZC #weightloss CJC Journals CCS @Els_Cardiology Derek S Chew @obrien_iph

Economic Outcomes with Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results from the PRECISE Randomized Trial curzen Derek S Chew Michael Nanna Daniel Mark #AHAJournals ahajrnls.org/4hGtrlU


Quality of Life Outcomes with a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients with Suspected Coronary Disease: Results from the PRECISE Randomized Trial Gregg W. Stone MD bchow @jweirmccall Derek S Chew Michael Nanna Daniel Mark ahajrnls.org/3Ell68Q
